Harlan Laboratories Taps Industry Veteran Dr. Philip Damiani To Lead Contract Breeding Services
INDIANAPOLIS, April 11, 2013 /PRNewswire/ -- Harlan Laboratories, a leading contract research organization and research models and services company, today announced that well known industry veteran Philip Damiani, Ph.D. has joined the company as Head of Global Embryological Sciences and Transgenic Support.
Dr. Damiani brings both the scientific expertise and hands-on client experience needed as Harlan continues its strategic global growth. In his new role, Dr. Damiani will oversee the company's global contract breeding services, which include rederivation, cryopreservation, revitalization, colony management, contract breeding and quarantine services.
For more than 15 years, Dr. Damiani has worked extensively in the field of assisted reproductive technology, including sperm and embryo cryopreservation, in vitro fertilization and nuclear transfer (cloning) for a wide variety of species. He is considered an expert in the areas of transgenic breeding, embryological cryopreservation and also owns several patents for cloning methods, including domestic and non-domestic species.
"Philip is an ideal leader for our newly expanded contract breeding services given his extensive knowledge in assisted reproductive technology and experience managing a global team of research scientists," said Doug Vaughan, President, Research Models and Services at Harlan Laboratories. "His leadership acumen and track record of success working with research scientists in leading pharmaceutical and academic centers aligns perfectly with our corporate commitment of being the most dependable supplier of contract breeding services in the industry."Previously, Dr. Damiani served as Head of Global Embryology for Taconic, where he was responsible for coordinating scientific research and development within the company's embryology laboratories. Prior to his time at Taconic, Dr. Damiani held progressive leadership roles at Genetic Savings and Clone, Inc., Advanced Cell Technology and Infigen, Inc. Dr. Damiani received his B.S. in Zoology from the State University of New York at Oswego in 1988 and his doctorate from the University of Massachusetts in Reproductive Physiology in 1998. For more information, visit www.harlan.com. About Harlan Laboratories, Inc. Harlan Laboratories, Inc. is a leading provider of essential, pre-clinical and non-clinical contract research, research models, animal diets, and services to the pharmaceutical, biotech, medical device, agrochemical and chemical industries, as well as universities, government, and other research organizations. Our focus is on providing customers with products and services to optimize the discovery and safety of new medicines and compounds. CONTACT: Michael Clark Miller Brooks, Inc. 317.873.8100 firstname.lastname@example.org SOURCE Harlan Laboratories, Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts